126 related articles for article (PubMed ID: 11475416)
1. Cardiovascular regulation in TGR(mREN2)27 rats: 24h variation in plasma catecholamines, angiotensin peptides, and telemetric heart rate variability.
Schiffer S; Pummer S; Witte K; Lemmer B
Chronobiol Int; 2001 May; 18(3):461-74. PubMed ID: 11475416
[TBL] [Abstract][Full Text] [Related]
2. Influence of circadian time and age on glomerular angiotensin II receptors in normotensive Sprague-Dawley and transgenic hypertensive TGR(mREN2)27 rats.
Lemmer B; Rueff T; Reiter S; Huser L; Hauptfleisch S; Witte K
Chronobiol Int; 2001 May; 18(3):447-59. PubMed ID: 11475415
[TBL] [Abstract][Full Text] [Related]
3. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter.
Lemmer B; Schiffer S; Witte K; Gorbey S
Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythms in the renin-angiotensin system and adrenal steroids may contribute to the inverse blood pressure rhythm in hypertensive TGR(mREN-2)27 rats.
Lemmer B; Witte K; Schänzer A; Findeisen A
Chronobiol Int; 2000 Sep; 17(5):645-58. PubMed ID: 11023212
[TBL] [Abstract][Full Text] [Related]
5. Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of the brain, the heart, and the kidneys.
Lemmer B; Witte K; Enzminger H; Schiffer S; Hauptfleisch S
Chronobiol Int; 2003 Jul; 20(4):711-38. PubMed ID: 12916722
[TBL] [Abstract][Full Text] [Related]
6. Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats.
Witte K; Lemmer B
Chronobiol Int; 1999 May; 16(3):293-303. PubMed ID: 10373099
[TBL] [Abstract][Full Text] [Related]
7. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
[TBL] [Abstract][Full Text] [Related]
8. Day-night variation in the in vitro contractility of aorta and mesenteric and renal arteries in transgenic hypertensive rats.
Witte K; Hasenberg T; Rueff T; Hauptfleisch S; Schilling L; Lemmer B
Chronobiol Int; 2001 Jul; 18(4):665-81. PubMed ID: 11587089
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of nitric oxide, cyclic GMP, and catecholamines during rest and activity period in transgenic hypertensive rats.
Globig S; Witte K; Lemmer B
Chronobiol Int; 1999 May; 16(3):305-14. PubMed ID: 10373100
[TBL] [Abstract][Full Text] [Related]
10. Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways.
Witte K; Huser L; Knotter B; Heckmann M; Schiffer S; Lemmer B
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):101-9. PubMed ID: 11191827
[TBL] [Abstract][Full Text] [Related]
11. Differential development of early hypertension in heterozygous transgenic TGR(mREN2)27 rats.
Kreutz R; Fernandez-Alfonso MS; Paul M; Peters J
Clin Exp Hypertens; 1998 Apr; 20(3):273-82. PubMed ID: 9605382
[TBL] [Abstract][Full Text] [Related]
12. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
Zhuo J; Ohishi M; Mendelsohn FA
Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
[TBL] [Abstract][Full Text] [Related]
13. Role of central AT1 and V1 receptors in cardiovascular adaptation to hemorrhage in SD and renin TGR rats.
Paczwa P; Szczepańska-Sadowska E; Loń S; Ganten SL; Ganten D
Am J Physiol; 1999 Jun; 276(6):H1918-26. PubMed ID: 10362671
[TBL] [Abstract][Full Text] [Related]
14. Effects of SCN lesions on circadian blood pressure rhythm in normotensive and transgenic hypertensive rats.
Witte K; Schnecko A; Buijs RM; van der Vliet J; Scalbert E; Delagrange P; Guardiola-Lemaître B; Lemmer B
Chronobiol Int; 1998 Mar; 15(2):135-45. PubMed ID: 9562918
[TBL] [Abstract][Full Text] [Related]
15. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls.
Pons M; Schnecko A; Witte K; Lemmer B; Waterhouse JM; Cambar J
Am J Physiol; 1996 Oct; 271(4 Pt 2):R1002-8. PubMed ID: 8897993
[TBL] [Abstract][Full Text] [Related]
16. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
Peters J; Hilgers KF; Maser-Gluth C; Kreutz R
Clin Exp Hypertens; 1996 Oct; 18(7):933-48. PubMed ID: 8886477
[TBL] [Abstract][Full Text] [Related]
17. Circadian pacemaker function and entrainment during maturation of transgenic hypertensive TGR(mREN2)27 and Sprague-Dawley rats.
Canal-Corretger MM; Witte K; Lemmer B
Chronobiol Int; 2001 Jul; 18(4):627-40. PubMed ID: 11587086
[TBL] [Abstract][Full Text] [Related]
18. Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen.
Baltatu O; Janssen BJ; Bricca G; Plehm R; Monti J; Ganten D; Bader M
Hypertension; 2001 Feb; 37(2 Pt 2):408-13. PubMed ID: 11230309
[TBL] [Abstract][Full Text] [Related]
19. Altered melatonin production in TGR(mREN2)27 rats: on the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes.
Enzminger H; Witte K; Lemmer B
J Pineal Res; 2001 Oct; 31(3):256-63. PubMed ID: 11589761
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen.
Couto AS; Baltatu O; Santos RA; Ganten D; Bader M; Campagnole-Santos MJ
J Hypertens; 2002 May; 20(5):919-25. PubMed ID: 12011653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
